Vor Biopharma Inc. Quality Score

VOR

Could not load quality data

This may be a temporary issue. If it persists, the ticker may not be covered yet.

SourceQuality score computed from the 10-Q filed 26 Oct 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 31 Oct 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with VOR

CompareIntrinsic value

RGENRepligen Corporation

$178.20-0.04%35

EXELExelixis Inc.

$72.75+0.61%97

KYMRKymera Therapeutics Inc.

$136.25+7.21%25

TECHBio-Techne Corporation

$72.73+0.10%52

BIIBBiogen Inc.

$254.46+2.22%39

DBVTDBV Technologies S.A.

$9.94-1.68%10

PALIPalisade Bio Inc.

$1.25+1.63%20

VYGRVoyager Therapeutics Inc.

$1.87+2.19%10

Held by ETFs

VOR is in 26 US ETFs. The largest of them, with VOR's weight in each:

Spot a number that looks wrong? Check it in VOR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing VOR

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.